Uridine supplementation enhances hepatic mitochondrial function in thymidine-analogue treated HIV-infected patients

AIDS. 2006 Jul 13;20(11):1554-6. doi: 10.1097/01.aids.0000237373.38939.14.

Abstract

Supplementation with uridine offers the possibility of a new and promising approach to nucleoside analogue reverse transcriptase inhibitor-associated mitochondrial toxicity. We investigated the metabolic effects of short-course treatment with the uridine-enriched food supplement NucleomaxX on hepatic mitochondrial function in thymidine-analogue treated HIV-infected patients. Mitochondrial function was assessed by a recently introduced non-invasive C-methionine breath test. NucleomaxX supplementation enhanced mitochondrial decarboxylation function reversibly but reproducibly in all patients. Repeated administration in shorter treatment intervals may maintain this effect.

Publication types

  • Randomized Controlled Trial

MeSH terms

  • Anti-HIV Agents / adverse effects*
  • Breath Tests / methods
  • Dietary Supplements*
  • HIV-Associated Lipodystrophy Syndrome / drug therapy*
  • HIV-Associated Lipodystrophy Syndrome / physiopathology
  • Humans
  • Male
  • Mitochondria, Liver / drug effects*
  • Mitochondria, Liver / physiology
  • Reverse Transcriptase Inhibitors / adverse effects
  • Uridine / therapeutic use*

Substances

  • Anti-HIV Agents
  • Reverse Transcriptase Inhibitors
  • Uridine